Michael Garson Email & Phone Number

• Responsible for sales and training for Oncologists in the Mid-Atlantic region for Breast Cancer, Prostate Cancer and Surgical Navigation Products
• Responsible for selling Fracture Care Devices, Upper and Lower Extremity Implants & Wound Care portfolio
• Coordinated clinical education and sales to Interventional Cardiologists for AI medical device for rapid rule out of Coronary Artery Disease
• Manage territory key accounts for the sales productivity and profitability of the territory.
• Negotiate Hospital, IDN and Organizational contracts for volume, exclusivity, P&T and Formulary Acceptance
• Buy and Bill, Reimbursement and HUB services expertise

• (Company dissolved division)
• Account Management for Surgical, ASC, Hospital and Clinic procedures
• Responsible for the successful launch and promotion of surgical implant Dextenza within the Ophthalmology community
• Facilitate clinical training of Dextenza to Ophthalmology, Cataract, Retina and Glaucoma specialists
• Assist accounts with becoming proficient with the reimbursement process to position products for adoption and usage in a Buy and Bill environment
• Act as a liaison to help accounts understand and manage local payer reimbursement policies and market access

• Responsible for sales and training for Oncologists, Hematologists and Pharmacists in the Mid-Atlantic region for Breast Cancer, Gastric Cancers and Febrile Neutropenia products
• Manage territory key accounts and accountable for the sales productivity and profitability of the territory
• Responsible for selling injectable Biosimilar Oncology products to all Oncologists and Pharmacy Directors in the Mid-Atlantic including Hospitals IDN’s and Infusion Centers
• Buy and Bill, Market Access, HUB services and Reimbursement expertise
• Achieved and exceeded sales quota consistently, top 10% performer in division
• Assisted in contract negotiations for Hospitals, IDN’s and Cancer Centers with P&T Committee and VAC Committee to convert and close business for Formulary wins

• (Boston Scientific acquired company and position was eliminated)
• Sales and Account Management for a Portfolio of minimally invasive Disruptive Capital Equipment and Medical Devices for Liver Directed Therapy
• Partnered with Transplant Specialists, Imaging Team, Rare Disease Oncologists, Interventional Oncologists, Interventional Radiologists, GI Specialists and Oncologists
• Develop, implement and lead strategic marketing plans with referring physicians to attain corporate goals
• Establish relationships with KOL’s and develop new KOL’s in targeted accounts
• Deliver C-Suite presentations and Cost/Benefit analysis proposals

Mid Atlantic Region

• Develop and implement Oncology strategies to execute operations and marketing plans
• Provide C-Suite presentations and ROI analysis
• Focus on product positioning, market penetration and building a preference for SIR-Spheres Resin Microspheres in the Oncology community for a unique FDA approved Disruptive Targeted Medical Device for Liver Tumors and.
• Partnered with Transplant Team Specialists, Imaging and Radiology Teams, GI Specialists, Interventional Oncologists, Interventional Radiologists and Oncologists
• Oversee Market Research Council Marketing Programs
• Grew 2016 sales by 43% over previous year (311 vs 219)

Mid Atlantic Region

• (Dissolved Oncology Franchise)
• Responsible for sales of Gliadel, an Implantable Chemotherapy Medical Device
• Launched Gliadel to Mid Atlantic Neurosurgical Specialists, Hospitalists, ED & Critical Care Clinicians
• Ranked 5 out of 22 territories, 115% to quota for Gliadel
• Successfully launched Nymalize, (oral nimodipine) treatment for subarachnoid hemorrhage to Hospitalists, ED and Critical Care Clinicians
• Achieved 195% to quota during launch